15-89777265-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001039958.2(MESP2):āc.908T>Cā(p.Leu303Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,611,070 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001039958.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MESP2 | NM_001039958.2 | c.908T>C | p.Leu303Pro | missense_variant | 1/2 | ENST00000341735.5 | NP_001035047.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MESP2 | ENST00000341735.5 | c.908T>C | p.Leu303Pro | missense_variant | 1/2 | 1 | NM_001039958.2 | ENSP00000342392.3 | ||
MESP2 | ENST00000560219.2 | c.31-800T>C | intron_variant | 1 | ENSP00000452998.1 | |||||
MESP2 | ENST00000558723.1 | n.39-800T>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00189 AC: 288AN: 152250Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00470 AC: 1123AN: 239054Hom.: 23 AF XY: 0.00400 AC XY: 526AN XY: 131586
GnomAD4 exome AF: 0.00155 AC: 2258AN: 1458702Hom.: 50 Cov.: 34 AF XY: 0.00141 AC XY: 1023AN XY: 725436
GnomAD4 genome AF: 0.00189 AC: 288AN: 152368Hom.: 4 Cov.: 32 AF XY: 0.00216 AC XY: 161AN XY: 74516
ClinVar
Submissions by phenotype
Spondylocostal dysostosis 2, autosomal recessive Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 09, 2019 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
MESP2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at